RxSight, Inc.
For the period ended Jun 30, 2026. Filed Aug 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 5, 2026
RXST$4.540.0%Stored close · as of Nov 6, 2026
Contents
Condensed Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| June 30, | December 31, | |
|---|---|---|
| 2026 | 2025 | |
| (Unaudited) | ||
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $13,352 | $19,949 |
| Short-term investments | 195,447 | 208,179 |
| Accounts receivable, net | 18,519 | 23,383 |
| Inventories | 37,117 | 31,559 |
| Prepaid and other current assets | 2,961 | 4,389 |
| Receivable from collaboration partner | 60,000 | — |
| Total current assets | 327,396 | 287,459 |
| Property and equipment, net | 14,039 | 13,056 |
| Operating leases right-of-use assets | 9,491 | 9,959 |
| Restricted cash | 750 | 750 |
| Other assets | 1,024 | 590 |
| Total assets | $352,700 | $311,814 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $6,345 | $5,296 |
| Accrued expenses and other current liabilities | 15,553 | 16,533 |
| Lease liabilities | 1,664 | 1,162 |
| Deferred revenue, current | 6,882 | 3,262 |
| Refund liability | 50,000 | — |
| Total current liabilities | 80,444 | 26,253 |
| Long-term lease liabilities | 8,916 | 9,878 |
| Total liabilities | 89,360 | 36,131 |
| Commitments and contingencies (Note 8) | ||
| Stockholders' equity: | ||
| Common stock, $0.001 par value, 900,000,000 shares authorized, 41,585,381 shares issued and outstanding as of June 30, 2026 and 41,242,005 shares issued and outstanding as of December 31, 2025 | 41 | 41 |
| Preferred stock, $0.001 par value, 100,000,000 shares authorized, no shares issued and outstanding | — | — |
| Additional paid-in capital | 952,378 | 936,628 |
| Accumulated other comprehensive (loss) income | (59) | 53 |
| Accumulated deficit | (689,020) | (661,039) |
| Total stockholders' equity | 263,340 | 275,683 |
| Total liabilities and stockholders' equity | $352,700 | $311,814 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.